Latest funding opportunities listed:
"The AbbVie IIS Program provides an opportunity to academic and community-based physicians and researchers worldwide interested in conducting their own research to apply for research support. See website for AbbVie's Therapeutic Areas of Interests. "
Deadline for Concept Paper: ContinuousRead More
"ARRE will support basic scientific and clinical research that can further characterize the molecular causes and pathogenicity of the ASXL gene family, improve medical care plans, and meet the needs for families who face extraordinary challenges and uncertainty. "
Deadline: September 15, 2018Read More
"CRI offers its Clinic and Laboratory Integration Program (CLIP) Grants to qualified scientists who are working to explore clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies. The program supports basic, pre-clinical, and translational research that can be directly applied to optimizing cancer immunotherapy in the clinic. "
Deadline for Letter of Intent: November 1, 2018Read More
"The Cancer Research Institute Technology Impact Award provides seed funding to be used over 12-24 months to address the gap between technology development and clinical application of cancer immunotherapies. These grants aim to encourage collaboration between technology developers and clinical cancer immunologists and to generate the proof-of-principle of a novel platform technology in bioinformatics, ex vivo or in silico modeling systems, immunological or tumor profiling instrumentation, methods, reagents and assays, or other relevant technologies that can enable clinician scientists to generate deeper insights into the mechanisms of action of effective or ineffective cancer immunotherapies. "
Deadline for Letter of Intent: November 15, 2018Read More
Spinal Cord Injury Research on the Translational Spectrum (SCIRTS) portfolio funding is intended to support research designed to improve understanding and advance the treatment of acute and chronic SCI and to fill gaps in the field, including mechanistic, preclinical, translational and/or clinical studies. SCIRTS Senior Research Grants are for individuals who are senior, independent investigators (equivalent to Associate Professor or above) at the time of the FGA submission. SCIRTS Pilot Research Grants are for independent investigators, and can be at any stage of their research career (junior or senior/established).
Deadline for letter of Intent: May 4, 2018Read More
The Grant-In-Aid program will provide targeted funding to enable research projects on Angelman Syndrome to proceed at a rapid pace.
Deadline: ContinuousRead More
The Global Research Outreach (GRO) Program is an important part of growing SAMSUNG's academic research engagement and collaboration platforms. World-class researchers have been annually invited since 2009 to propose novel research ideas and to work with SAMSUNG's R&D teams to foster technological innovation. The GRO Program is seeking proposals in 27 research themes. Other themes are also welcome.
Deadline: June 11, 2018Read More
Purpose of the grant is to fund research that will develop strategies leading to the development of therapies for the prevention of the transition from pre-leukemia to leukemia for patients with the familial RUNX1 disorder. Projects should focus on familial RUNX1 disorder rather than acquired RUNX1 mutations seen during the evolution of AML.
Deadline for letter of intent: July 2, 2018Read More
The Champ Foundation supports research toward better treatment and a cure for diseases caused by mitochondrial DNA deletions, namely Pearson Syndrome. We are releasing a call for proposals to find and fund the most innovative research projects aligned with this mission.
Deadline: May 25, 2018Read More
"The National Ataxia Foundation (NAF) is committed to funding the best science relevant to hereditary and sporadic types of ataxia in both basic and translational research. "
"Deadline for letter of intent: July 16, 2018 Deadline for application: August 15, 2018"Read More
The program supports research on Lyme and associated tick-borne diseases. The Foundation's goal is to increase knowledge and understanding of borreliosis in Canada, and to support high quality research that informs Canadian public health policy. The primary focus is research that has potential application to human illness.
Deadline for Letter of Intent: ContinuousRead More
The purpose of the Reach Grant is to advance ALSF's mission to find cures and better treatments for childhood cancers by providing support to move hypothesis-driven research into the clinic.
Deadline: May 21, 2018Read More
The Brain Tumor Funders' Collaborative (BTFC) works to identify potential therapies for patients with primary human brain tumors to ultimately increase overall patient survival, increase progression-free patient survival and improve the quality of life of patients affected by a primary brain tumor. The BTFC is prepared to sponsor research on the role of the neuro-immune system in the origin and progression of the immune responses in primary human brain tumors with the hope of developing immunotherapies for treatment of these tumors in patients. This Request for Pre-proposals focuses on supporting studies on the immune responses in primary brain tumors in pediatric and/or adult human patients.
"Deadline for preliminary proposal: May 11, 2018 Deadline for full proposal: July 13, 2018"Read More
"Research grants are intended to support basic science research. Studies may be carried out at the subcellular, cellular, animal, or patient levels. To be considered, proposals must be hypothesis-driven and provide sufficient preliminary data to justify Cystic Fibrosis Foundation support. Priority will be placed on those projects that propose to better understand the mechanisms behind disease pathophysiology and to develop strategies to prevent or treat CF. "
Deadlines for proposals: May 7, 2018; December 3, 2018Read More
This grants program was established to encourage and support research into the potential causes and other key aspects of this condition that may lead to improvements in its treatment and potential prevention or cure.
Deadline: June 15, 2018Read More
These awards are for developing and testing new hypotheses and/or new methods, and supporting promising new investigators as they establish themselves in research areas relevant to cystic fibrosis.
Deadlines: May 7, 2018; December 3, 2018Read More
"Funding research into all aspects of oral tissue regeneration is a core task of the Osteology Foundation. "
Deadlines for Abstracts: June 15, 2018; December 1, 2018Read More
Research Network: Rare Diseases (Research Network: Expediting collaboration between basic and clinician scientists in functional studies of novel rare disease genes)
"This program seeks to support a Rare Disease Network aiming at maintaining Canada's leadership in enabling clinical geneticists who are identifying rare disease gene mutations to collaborate with model organism researchers with expertise in the cognate gene's function, and to develop the capacity to study genes for which no suitable models can be identified in Canada or in other countries with similar networks. This will provide a powerful incentive for expanded international collaborations between Canadian model organism researchers and clinical geneticists elsewhere, and will enable reciprocal arrangements whereby model organism researchers elsewhere will be funded by other networks to collaborate with Canadian clinicians. "
Deadline: May 1, 2018Read More
The LAM Foundation offers grant opportunities for researchers interested in studying lymphangioleiomyomatosis.
Deadline for letter of intent: June 15, 2018Read More
The 2018 Advancing Science through Pfizer: Investigator Research Exchange (ASPIRE) Gene and anti-TFPI Therapies for Hemophilia Global Research Awards Program is a competitive grants program that reflects the commitment of Pfizer Hemophilia Rare Disease group to support ongoing basic science and clinical investigation in gene and anti-TFPI therapies for hemophilia.
Deadline: May 31, 2018Read More
Friedreich's Ataxia Research Alliance - Bronya J. Keats Award for International Collaboration in Research on FA
FARA accepts LOIs focusing on FA research that relies on international collaboration among investigators in at least two different countries. Special consideration will be given to proposals that bring new scientists to the FA community.
"Deadline for Letters of Intent: May 15, 2018 Deadline for Application: July 15, 2018"Read More
"Shwachman-Diamond Syndrome (SDS) is a multi-system autosomal-recessive disorder characterized by exocrine pancreatic dysfunction, and varying degrees of marrow dysfunction with cytopenias.SDSF is accepting grant requests for research relevant to this disease. Any high quality, innovative research proposal deemed relevant to SDS will be considered. "
Deadline: May 15, 2018Read More
Last updated: April 9, 2018
Western researchers can consult Pivot , a comprehensive database of grant information.